Knoll Capital Management as of Dec. 31, 2013
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 14 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 79.8 | $159M | 2.5M | 63.82 | |
| Ampio Pharmaceuticals | 7.3 | $15M | 2.0M | 7.13 | |
| Alcobra | 6.2 | $12M | 687k | 18.00 | |
| Keryx Biopharmaceuticals | 1.3 | $2.6M | 200k | 12.96 | |
| Sequenom | 1.0 | $2.1M | 894k | 2.32 | |
| Synthetic Biologics | 1.0 | $2.1M | 1.4M | 1.51 | |
| Newlink Genetics Corporation | 0.9 | $1.7M | 77k | 22.00 | |
| Inovio Pharmaceuticals | 0.6 | $1.2M | 408k | 2.86 | |
| Vivus Inc option | 0.5 | $1.1M | 5.0k | 210.00 | |
| Advaxis | 0.5 | $947k | 225k | 4.21 | |
| ParkerVision | 0.5 | $910k | 200k | 4.55 | |
| Merrimack Pharmaceuticals In | 0.2 | $400k | 75k | 5.33 | |
| Advaxis Inc. w exp 07/15/201 | 0.1 | $186k | 113k | 1.65 | |
| Echo Therapeutics | 0.1 | $140k | 44k | 3.15 |
